Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. ICRP Glossary‏‎ (267 revisions)
  2. Application of ionising radiation in healthcare‏‎ (98 revisions)
  3. Information for healthcare providers‏‎ (80 revisions)
  4. Information for patients, family members, carers and the public‏‎ (62 revisions)
  5. System Of Radiation Protection Overview‏‎ (43 revisions)
  6. Guide to Radiological Protection in Healthcare‏‎ (43 revisions)
  7. General Information on Radon‏‎ (31 revisions)
  8. Main Page‏‎ (29 revisions)
  9. Information for healthcare providers (old)‏‎ (24 revisions)
  10. Information for patients, family members, carers and the public (old)‏‎ (24 revisions)
  11. Application of ionising radiation in healthcare (old)‏‎ (24 revisions)
  12. Effective dose‏‎ (23 revisions)
  13. Radon For Governments and Employers‏‎ (23 revisions)
  14. Radon For Homeowners and Residents‏‎ (22 revisions)
  15. The System of Radiological Protection‏‎ (21 revisions)
  16. Guide to Radon‏‎ (19 revisions)
  17. Tissue weighting factor‏‎ (17 revisions)
  18. List of ICRP Publications on Radiological Protection in Healthcare‏‎ (16 revisions)
  19. System of radiation protection module 2‏‎ (14 revisions)
  20. ICRP publications‏‎ (14 revisions)
  21. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  22. Equivalent dose‏‎ (11 revisions)
  23. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  24. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  25. Absorbed dose‏‎ (9 revisions)
  26. Objectives of Radiological Protection‏‎ (9 revisions)
  27. Air-kerma rate constant‏‎ (9 revisions)
  28. Organ/tissue absorbed dose‏‎ (8 revisions)
  29. Effects of Exposure‏‎ (8 revisions)
  30. Prudence‏‎ (8 revisions)
  31. Beneficence‏‎ (8 revisions)
  32. Collective effective dose‏‎ (7 revisions)
  33. Investigation level‏‎ (6 revisions)
  34. Alimentary tract‏‎ (6 revisions)
  35. ICRPædia Guides‏‎ (6 revisions)
  36. Justice‏‎ (6 revisions)
  37. Linear energy transfer‏‎ (6 revisions)
  38. Accelerated fractionation‏‎ (6 revisions)
  39. Exposure Categories and Situations‏‎ (6 revisions)
  40. Principle of optimisation‏‎ (5 revisions)
  41. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  42. Absorbed fraction‏‎ (5 revisions)
  43. Justification‏‎ (5 revisions)
  44. Protection quantities‏‎ (5 revisions)
  45. Kerma‏‎ (5 revisions)
  46. Types of materials‏‎ (5 revisions)
  47. Radiation weighting factor‏‎ (5 revisions)
  48. Air-kerma, entrance surface‏‎ (5 revisions)
  49. Sources of Radiation Exposure‏‎ (5 revisions)
  50. Quality factor‏‎ (5 revisions)
  51. Dose coefficient‏‎ (5 revisions)
  52. Sievert‏‎ (4 revisions)
  53. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  54. High linear energy transfer radiation‏‎ (4 revisions)
  55. S coefficient (radiation weighted)‏‎ (4 revisions)
  56. Non-maleficence‏‎ (4 revisions)
  57. Bioassay‏‎ (4 revisions)
  58. Calculating Radon Doses‏‎ (4 revisions)
  59. Computed tomography dose index‏‎ (4 revisions)
  60. Direct bioassay‏‎ (4 revisions - redirect page)
  61. Mass median diameter‏‎ (4 revisions)
  62. Alpha decay‏‎ (4 revisions)
  63. Programmed cell death‏‎ (4 revisions)
  64. Effective charge number‏‎ (4 revisions)
  65. Math‏‎ (4 revisions)
  66. Averted dose‏‎ (4 revisions)
  67. Effective half-life‏‎ (4 revisions)
  68. Protective action‏‎ (4 revisions)
  69. Reference Animal and Plant‏‎ (4 revisions)
  70. Kp index‏‎ (4 revisions)
  71. ICRP‏‎ (4 revisions)
  72. Source-related assessment‏‎ (4 revisions)
  73. Forbiddenness‏‎ (4 revisions)
  74. Aerodynamic diameter‏‎ (4 revisions)
  75. Reference bioassay function‏‎ (4 revisions)
  76. Diagnostic reference level‏‎ (4 revisions)
  77. Risk‏‎ (4 revisions)
  78. Senescence‏‎ (4 revisions)
  79. Air-kerma, product‏‎ (4 revisions)
  80. Fractionation sensitivity‏‎ (4 revisions)
  81. Optimisation‏‎ (4 revisions)
  82. Personal dose equivalent‏‎ (3 revisions)
  83. Principle of justification‏‎ (3 revisions)
  84. Radiofrequency ablation‏‎ (3 revisions)
  85. Emergency preparedness‏‎ (3 revisions)
  86. Valvular heart disease‏‎ (3 revisions)
  87. Gray‏‎ (3 revisions)
  88. Auger transition‏‎ (3 revisions)
  89. Bystander effect‏‎ (3 revisions)
  90. Iso-effect plots‏‎ (3 revisions)
  91. Emergency procedures‏‎ (3 revisions)
  92. Lifetime risk estimates‏‎ (3 revisions)
  93. Absolute risk‏‎ (3 revisions)
  94. Virtue ethics‏‎ (3 revisions)
  95. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  96. Complex tissues‏‎ (3 revisions)
  97. Derived air concentration‏‎ (3 revisions)
  98. Dignity‏‎ (3 revisions)
  99. Isomers‏‎ (3 revisions)
  100. Employer‏‎ (3 revisions)
  101. Activity median thermodynamic diameter‏‎ (3 revisions)
  102. Voxel phantom‏‎ (3 revisions)
  103. Growth fraction‏‎ (3 revisions)
  104. Organ dose equivalent‏‎ (3 revisions)
  105. ICRP Publication 103‏‎ (3 revisions)
  106. Excretion rate (instantaneous)‏‎ (3 revisions)
  107. Extrathoracic airways‏‎ (3 revisions)
  108. Galactic cosmic radiation‏‎ (3 revisions)
  109. Growth hormone (somatotropin)‏‎ (3 revisions)
  110. Recovery‏‎ (3 revisions)
  111. DNA damage signalling‏‎ (3 revisions)
  112. Spread-out Bragg peak‏‎ (3 revisions)
  113. Fairness‏‎ (3 revisions)
  114. Absorption‏‎ (3 revisions)
  115. Gamma ray‏‎ (3 revisions)
  116. Biomedical research volunteer‏‎ (3 revisions)
  117. Cardiomyopathy‏‎ (3 revisions)
  118. Dose equivalent‏‎ (3 revisions)
  119. Field-size effect (Volume effect)‏‎ (3 revisions)
  120. Gastrointestinal syndrome‏‎ (3 revisions)
  121. Wisdom‏‎ (3 revisions)
  122. Autonomy‏‎ (3 revisions)
  123. Dose limit‏‎ (3 revisions)
  124. Target region‏‎ (3 revisions)
  125. Flexible tissues‏‎ (3 revisions)
  126. Guide to the System of Radiological Protection‏‎ (3 revisions)
  127. Constancy test‏‎ (3 revisions)
  128. Dose‏‎ (3 revisions)
  129. Dose limits‏‎ (3 revisions)
  130. Fluence‏‎ (3 revisions)
  131. Potential exposure‏‎ (3 revisions)
  132. DS02‏‎ (3 revisions)
  133. Fluoroscopically guided interventions‏‎ (3 revisions)
  134. Annual dose‏‎ (3 revisions)
  135. Cell death‏‎ (3 revisions)
  136. Contamination‏‎ (3 revisions)
  137. Rigidity threshold‏‎ (3 revisions)
  138. Dose of record (E)‏‎ (3 revisions)
  139. Low Earth orbit‏‎ (3 revisions)
  140. Accountability‏‎ (3 revisions)
  141. X ray‏‎ (3 revisions)
  142. Half-life, physical‏‎ (3 revisions)
  143. Annual limit on intake‏‎ (3 revisions)
  144. Exponential survival curve‏‎ (3 revisions)
  145. Unsealed source‏‎ (3 revisions)
  146. Xerostomia‏‎ (3 revisions)
  147. Public exposure‏‎ (3 revisions)
  148. Dose per content function‏‎ (3 revisions)
  149. Interphase death‏‎ (3 revisions)
  150. Equity‏‎ (3 revisions)
  151. Test‏‎ (3 revisions)
  152. Graded approach‏‎ (3 revisions)
  153. Fractionation‏‎ (3 revisions)
  154. Uptake‏‎ (3 revisions)
  155. Active (red) bone marrow‏‎ (3 revisions)
  156. Utilitarian ethics‏‎ (3 revisions)
  157. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  158. Operational quantity‏‎ (3 revisions)
  159. Coster-Kronig transition‏‎ (3 revisions)
  160. Value judgement‏‎ (3 revisions)
  161. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  162. High level waste‏‎ (2 revisions)
  163. Clearance‏‎ (2 revisions)
  164. Deontological Ethics‏‎ (2 revisions)
  165. Repopulation‏‎ (2 revisions)
  166. Differentiation‏‎ (2 revisions)
  167. Routine monitoring‏‎ (2 revisions)
  168. ICRPædia Guide to Radon‏‎ (2 revisions)
  169. Special (non-routine) monitoring‏‎ (2 revisions)
  170. Lifetime risk‏‎ (2 revisions)
  171. Macrophage colony stimulating factor‏‎ (2 revisions)
  172. Multiplicative risk projection model‏‎ (2 revisions)
  173. Activity‏‎ (2 revisions)
  174. Beta-minus decay‏‎ (2 revisions)
  175. Clearance level‏‎ (2 revisions)
  176. Radiographer‏‎ (2 revisions)
  177. Representative organism (non-human biota)‏‎ (2 revisions)
  178. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  179. Dose constraint‏‎ (2 revisions)
  180. Early normal tissue responses‏‎ (2 revisions)
  181. Threshold dose for tissue reactions‏‎ (2 revisions)
  182. Magnetosphere‏‎ (2 revisions)
  183. Pharynx‏‎ (2 revisions)
  184. Beta-plus decay‏‎ (2 revisions)
  185. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  186. Cumulative dose‏‎ (2 revisions)
  187. Representative person‏‎ (2 revisions)
  188. Safety‏‎ (2 revisions)
  189. Dose conversion coefficient‏‎ (2 revisions)
  190. Edema‏‎ (2 revisions)
  191. Specific effective energy‏‎ (2 revisions)
  192. Limitation of dose‏‎ (2 revisions)
  193. Excess relative risk‏‎ (2 revisions)
  194. Exposure situation‏‎ (2 revisions)
  195. Transmission detection system‏‎ (2 revisions)
  196. Multistage tumorigenesis‏‎ (2 revisions)
  197. Non-sphericity parameter‏‎ (2 revisions)
  198. Growth factor‏‎ (2 revisions)
  199. Alimentary tract transfer factor‏‎ (2 revisions)
  200. Hormones‏‎ (2 revisions)
  201. Authorization‏‎ (2 revisions)
  202. Procedural values‏‎ (2 revisions)
  203. Clonogenic cells‏‎ (2 revisions)
  204. Curie‏‎ (2 revisions)
  205. Reproductive integrity‏‎ (2 revisions)
  206. Safety case‏‎ (2 revisions)
  207. Slow repair‏‎ (2 revisions)
  208. Effect Dose 50‏‎ (2 revisions)
  209. Isotropic geometry‏‎ (2 revisions)
  210. Endogeneous excretion‏‎ (2 revisions)
  211. Lineal energy‏‎ (2 revisions)
  212. Thyroid blocking‏‎ (2 revisions)
  213. Exposure to Radon at Home‏‎ (2 revisions)
  214. Transparency‏‎ (2 revisions)
  215. GATA binding protein 2‏‎ (2 revisions)
  216. Waste disposal‏‎ (2 revisions)
  217. Non-targeted effects‏‎ (2 revisions)
  218. Hounsfield unit‏‎ (2 revisions)
  219. Authorized limit‏‎ (2 revisions)
  220. Planned exposure situation‏‎ (2 revisions)
  221. Progenitor cell‏‎ (2 revisions)
  222. Cardiac arrhythmias‏‎ (2 revisions)
  223. Radiation belt‏‎ (2 revisions - redirect page)
  224. Clonogenic survival‏‎ (2 revisions)
  225. Reasonableness‏‎ (2 revisions)
  226. Cytokines‏‎ (2 revisions)
  227. Residual dose‏‎ (2 revisions)
  228. Safety culture‏‎ (2 revisions)
  229. Solar cosmic radiation‏‎ (2 revisions)
  230. Inhalability‏‎ (2 revisions)
  231. Spontaneous fission‏‎ (2 revisions)
  232. Itinerant (radiation) worker‏‎ (2 revisions)
  233. Linear-non-threshold model‏‎ (2 revisions)
  234. Trapped particles‏‎ (2 revisions)
  235. Acute radiation syndrome‏‎ (2 revisions)
  236. Orphan source‏‎ (2 revisions)
  237. Autoimmune disease‏‎ (2 revisions)
  238. Platelet-derived growth factor‏‎ (2 revisions)
  239. ICRP Publication 118‏‎ (2 revisions)
  240. Cardiac valve diseases‏‎ (2 revisions)
  241. Radiation modifier‏‎ (2 revisions)
  242. Radiological protection principles‏‎ (2 revisions)
  243. Respiratory protection‏‎ (2 revisions)
  244. Disposal‏‎ (2 revisions)
  245. Scintigraphy‏‎ (2 revisions)
  246. Dose criteria‏‎ (2 revisions)
  247. Solar cycle‏‎ (2 revisions)
  248. Inner bremsstrahlung‏‎ (2 revisions)
  249. Environmental exposure‏‎ (2 revisions)
  250. Systemic model‏‎ (2 revisions)
  251. Linear-quadratic dose response model‏‎ (2 revisions)
  252. Exempt waste‏‎ (2 revisions)
  253. Time factor‏‎ (2 revisions)
  254. Myocardial perfusion‏‎ (2 revisions)
  255. Adaptive response‏‎ (2 revisions)
  256. What is Radon?‏‎ (2 revisions)
  257. Alveolar-interstitial region‏‎ (2 revisions)
  258. Projected dose‏‎ (2 revisions)
  259. Co-expertise‏‎ (2 revisions)
  260. Radionuclides of natural origin‏‎ (2 revisions)
  261. Connective tissue‏‎ (2 revisions)
  262. Recovery (cellular or tissue)‏‎ (2 revisions)
  263. DRL process‏‎ (2 revisions)
  264. Retrievability‏‎ (2 revisions)
  265. Immune system‏‎ (2 revisions)
  266. Institutional control‏‎ (2 revisions)
  267. Stakeholder‏‎ (2 revisions)
  268. Environmental radiation protection‏‎ (2 revisions)
  269. Tachycardia‏‎ (2 revisions)
  270. Exemption level‏‎ (2 revisions)
  271. Tissue equivalent material‏‎ (2 revisions)
  272. Myocardial stress test‏‎ (2 revisions)
  273. Oversight‏‎ (2 revisions)
  274. Hyperbaric oxygen‏‎ (2 revisions)
  275. Bioturbation‏‎ (2 revisions)
  276. Cardioverter-defibrillator‏‎ (2 revisions)
  277. Radiation safety officer‏‎ (2 revisions)
  278. Radioresponsiveness‏‎ (2 revisions)
  279. Consequential late effects‏‎ (2 revisions)
  280. Recovery responder‏‎ (2 revisions)
  281. Reversibility‏‎ (2 revisions)
  282. In vivo radiobioassay‏‎ (2 revisions)
  283. Solar particle event‏‎ (2 revisions)
  284. Effective dose equivalent‏‎ (2 revisions)
  285. Existing exposure situation‏‎ (2 revisions)
  286. Gastroschisis‏‎ (2 revisions)
  287. Worker‏‎ (2 revisions)
  288. Nuclear track detectors‏‎ (2 revisions)
  289. Angiogenesis‏‎ (2 revisions)
  290. Particle radiance‏‎ (2 revisions)
  291. Hyperfractionation‏‎ (2 revisions)
  292. Bone marrow‏‎ (2 revisions)
  293. Protection strategy‏‎ (2 revisions)
  294. Radiation source‏‎ (2 revisions)
  295. Cohort study‏‎ (2 revisions)
  296. Radiosensitiser‏‎ (2 revisions)
  297. DRL value‏‎ (2 revisions)
  298. Rehabilitation of living conditions‏‎ (2 revisions)
  299. Right to know‏‎ (2 revisions)
  300. Incidence‏‎ (2 revisions)
  301. Solar wind‏‎ (2 revisions)
  302. Epithelium‏‎ (2 revisions)
  303. Target tissue‏‎ (2 revisions)
  304. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  305. Acceptance test‏‎ (2 revisions)
  306. Gastrulation‏‎ (2 revisions)
  307. Working level‏‎ (2 revisions)
  308. OLINDA/EXM‏‎ (2 revisions)
  309. Habitual mouth breather‏‎ (2 revisions)
  310. Annihilation photons‏‎ (2 revisions)
  311. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  312. Background dose (rate)‏‎ (2 revisions)
  313. Radiosensitivity, cellular‏‎ (2 revisions)
  314. Containment‏‎ (2 revisions)
  315. Rigidity‏‎ (2 revisions)
  316. Dose-length product‏‎ (2 revisions)
  317. Security‏‎ (2 revisions)
  318. Incident‏‎ (2 revisions)
  319. Intermediate level waste‏‎ (2 revisions)
  320. Stenosis‏‎ (2 revisions)
  321. Equieffective dose‏‎ (2 revisions)
  322. Local DRL‏‎ (2 revisions)
  323. Expanded and aligned radiation field‏‎ (2 revisions)
  324. Tolerability‏‎ (2 revisions)
  325. Medical exposure‏‎ (2 revisions)
  326. Naturally occurring radioactive material‏‎ (2 revisions)
  327. Adventitious‏‎ (2 revisions)
  328. Working level month‏‎ (2 revisions)
  329. Habitual nose breather‏‎ (2 revisions)
  330. Patient entrance reference point‏‎ (2 revisions)
  331. Hypoplasia‏‎ (2 revisions)
  332. Backscatter detection system‏‎ (2 revisions)
  333. Potential recoverability correction factor‏‎ (2 revisions)
  334. Bradycardia‏‎ (2 revisions)
  335. Protective action guide‏‎ (2 revisions)
  336. Radiation worker‏‎ (2 revisions)
  337. Detriment‏‎ (2 revisions)
  338. Dose-rate effect‏‎ (2 revisions)
  339. Inclusiveness‏‎ (2 revisions)
  340. Source-related‏‎ (2 revisions)
  341. Internal conversion electron‏‎ (2 revisions)
  342. Electron-capture decay‏‎ (2 revisions)
  343. LD 50/30‏‎ (2 revisions)
  344. Telangiectasia‏‎ (2 revisions)
  345. Member of the public‏‎ (2 revisions)
  346. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  347. Unattached fraction‏‎ (2 revisions)
  348. Necrosis‏‎ (2 revisions)
  349. Hazard‏‎ (2 revisions)
  350. Peak skin dose‏‎ (2 revisions)
  351. Bragg peak‏‎ (2 revisions)
  352. Radioactive dispersion device‏‎ (2 revisions)
  353. Radon: Units of Measure‏‎ (2 revisions)
  354. Coronary heart disease‏‎ (2 revisions)
  355. Reference air kerma‏‎ (2 revisions)
  356. Decay constant‏‎ (2 revisions)
  357. Self-help protection‏‎ (2 revisions)
  358. Individual-related‏‎ (2 revisions)
  359. Dose of record Hp (10)‏‎ (2 revisions)
  360. Electrophysiology‏‎ (2 revisions)
  361. Storage‏‎ (2 revisions)
  362. Track structure‏‎ (2 revisions)
  363. Mendelian diseases‏‎ (2 revisions)
  364. Accreditation‏‎ (2 revisions)
  365. Neurological syndrome‏‎ (2 revisions)
  366. Genomic integrity‏‎ (2 revisions)
  367. Occupational exposure‏‎ (2 revisions)
  368. Health Surveillance‏‎ (2 revisions)
  369. Pelagic‏‎ (2 revisions)
  370. Basal cell‏‎ (2 revisions)
  371. Practical radiological protection culture‏‎ (2 revisions)
  372. Branching fraction‏‎ (2 revisions)
  373. Chronic exposure‏‎ (2 revisions)
  374. Radioactive source‏‎ (2 revisions)
  375. Colony‏‎ (2 revisions)
  376. Cosmic Radiation in Aviation‏‎ (2 revisions)
  377. Decommissioning‏‎ (2 revisions)
  378. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  379. Dose-threshold‏‎ (2 revisions)
  380. Individual decontamination‏‎ (2 revisions)
  381. Subcutaneous tissue‏‎ (2 revisions)
  382. Low dose rate‏‎ (2 revisions)
  383. Transfer compartment‏‎ (2 revisions)
  384. Mitigation‏‎ (2 revisions)
  385. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  386. Action Level‏‎ (2 revisions)
  387. Upper reference levels‏‎ (2 revisions)
  388. Neurovascular syndrome‏‎ (2 revisions)
  389. Heliosphere‏‎ (2 revisions)
  390. Qualified expert‏‎ (2 revisions)
  391. Class SR-0 gases‏‎ (2 revisions)
  392. Radioactive substance‏‎ (2 revisions)
  393. Reference biokinetic model‏‎ (2 revisions)
  394. Decontamination‏‎ (2 revisions)
  395. Relocation‏‎ (2 revisions)
  396. Diastasis‏‎ (2 revisions)
  397. Risk coefficient‏‎ (2 revisions)
  398. Individual monitoring‏‎ (2 revisions)
  399. Dose per unit intake coefficient‏‎ (2 revisions)
  400. Source term‏‎ (2 revisions)
  401. Emergency‏‎ (2 revisions)
  402. Latent time/period or latency interval‏‎ (2 revisions)
  403. Low level waste‏‎ (2 revisions)
  404. Exposure, external or internal‏‎ (2 revisions)
  405. Graft vs host disease‏‎ (2 revisions)
  406. Air-kerma, incident‏‎ (2 revisions)
  407. Percutaneous coronary intervention‏‎ (2 revisions)
  408. Prevailing circumstances‏‎ (2 revisions)
  409. Broad beam therapy irradiation technique‏‎ (2 revisions)
  410. Class SR-1 gases‏‎ (2 revisions)
  411. Committed effective dose‏‎ (2 revisions)
  412. Radon Recommendations for Authorities‏‎ (2 revisions)
  413. Cost-benefit analysis‏‎ (2 revisions)
  414. Reference individual‏‎ (2 revisions)
  415. Decontamination factor‏‎ (2 revisions)
  416. Remedial action‏‎ (2 revisions)
  417. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  418. Dose rate‏‎ (2 revisions)
  419. Intervention Level‏‎ (2 revisions)
  420. Emergency exposure situation‏‎ (2 revisions)
  421. Substantial radiation dose level‏‎ (2 revisions)
  422. Erythropoietin‏‎ (2 revisions)
  423. Exposure (in the context of inhalation)‏‎ (2 revisions)
  424. Transfer rate‏‎ (2 revisions)
  425. Multi-detector computed tomography‏‎ (2 revisions)
  426. Fractionation and dose delivery patterns‏‎ (2 revisions)
  427. Hierarchical tissues‏‎ (2 revisions)
  428. Area monitoring‏‎ (2 revisions)
  429. Pericarditis‏‎ (2 revisions)
  430. Benthic‏‎ (2 revisions)
  431. Principle of application of dose limits‏‎ (2 revisions)
  432. Bronchial region‏‎ (2 revisions)
  433. Class SR-2 gases‏‎ (2 revisions)
  434. Radioactivity‏‎ (2 revisions)
  435. Committed equivalent dose‏‎ (2 revisions)
  436. Radon Recommendations for Workplaces‏‎ (2 revisions)
  437. Reference level‏‎ (2 revisions)
  438. Remediation‏‎ (2 revisions)
  439. Dichotomous‏‎ (2 revisions)
  440. Risk of Exposure to Radon‏‎ (2 revisions)
  441. Dose rate effectiveness factor‏‎ (2 revisions)
  442. South Atlantic anomaly‏‎ (2 revisions)
  443. Interventional procedure‏‎ (2 revisions)
  444. Emergency plan‏‎ (2 revisions)
  445. Ethics‏‎ (2 revisions)
  446. Lymphatic system‏‎ (2 revisions)
  447. ALARA‏‎ (2 revisions)
  448. Transforming growth factor‏‎ (2 revisions)
  449. Attributable risk‏‎ (1 revision)
  450. ICRP Publication 101‏‎ (1 revision)
  451. Best available techniques‏‎ (1 revision)
  452. ICRP Publication 113‏‎ (1 revision)
  453. Bronchiolar region‏‎ (1 revision)
  454. Quasi-threshold dose‏‎ (1 revision)
  455. ICRP Publication 128‏‎ (1 revision)
  456. ICRP Publication 142‏‎ (1 revision)
  457. Compartment‏‎ (1 revision)
  458. Radon progeny‏‎ (1 revision)
  459. ICRP Publication 17‏‎ (1 revision)
  460. Count median diameter‏‎ (1 revision)
  461. Reference parameter value‏‎ (1 revision)
  462. ICRP Publication 30 (Index)‏‎ (1 revision)
  463. ICRP Publication 38‏‎ (1 revision)
  464. ICRP Publication 52‏‎ (1 revision)
  465. Dose commitment‏‎ (1 revision)
  466. ICRP Publication 67‏‎ (1 revision)
  467. Doubling dose‏‎ (1 revision)
  468. ICRP Publication 81‏‎ (1 revision)
  469. Supervised area‏‎ (1 revision)
  470. Evacuation‏‎ (1 revision)
  471. Thoron progeny‏‎ (1 revision)
  472. Exposure index‏‎ (1 revision)
  473. AML/eto‏‎ (1 revision)
  474. Transgenerational effect‏‎ (1 revision)
  475. Frequent flyer‏‎ (1 revision)
  476. Non-homologous end joining‏‎ (1 revision)
  477. Optimisation of protection‏‎ (1 revision)
  478. Phantom‏‎ (1 revision)
  479. ICRP Publication 101a‏‎ (1 revision)
  480. ICRP Publication 114‏‎ (1 revision)
  481. ICRP Publication 129‏‎ (1 revision)
  482. ICRP Publication 143‏‎ (1 revision)
  483. Compartment (environmental)‏‎ (1 revision)
  484. Ras‏‎ (1 revision)
  485. ICRP Publication 18‏‎ (1 revision)
  486. Cross section‏‎ (1 revision)
  487. Reference phantom‏‎ (1 revision)
  488. ICRP Publication 30 (Part 1)‏‎ (1 revision)
  489. Deposition‏‎ (1 revision)
  490. ICRP Publication 90‏‎ (1 revision)
  491. ICRP Publication 39‏‎ (1 revision)
  492. Digital breast tomosynthesis‏‎ (1 revision)
  493. ICRP Publication 53‏‎ (1 revision)
  494. Size-specific dose estimate‏‎ (1 revision)
  495. ICRP Publication 68‏‎ (1 revision)
  496. Specific absorbed fraction‏‎ (1 revision)
  497. ICRP Publication 82‏‎ (1 revision)
  498. Surface contamination‏‎ (1 revision)
  499. Excess absolute risk‏‎ (1 revision)
  500. Exposure pathway‏‎ (1 revision)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)